Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study. - Tursi A; Mocci G; Scaldaferri F; Napolitano D; Gaiani F; De' Angelis G; Giuseppe Ribaldone D; Schillaci E; Savarino EV; Barba CDE; Bendia E; Bolognini L; et al. (American journal of therapeutics, 2026)